BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 9144453)

  • 1. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced renal outer medullary uptake of mercury associated with uninephrectomy: implication of a luminal mechanism.
    Zalups RK
    J Toxicol Environ Health; 1997 Feb; 50(2):173-94. PubMed ID: 9048960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
    Zalups RK; Gelein RM; Cernichiari E
    J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different degrees of reduced renal mass on the renal and hepatic disposition of administered cadmium.
    Zalups RK
    J Toxicol Environ Health; 1997 Jun; 51(3):245-64. PubMed ID: 9183381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of uninephrectomy and mercuric chloride on renal glutathione homeostasis.
    Zalups RK; Lash LH
    J Pharmacol Exp Ther; 1990 Sep; 254(3):962-70. PubMed ID: 2395124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystine alters the renal and hepatic disposition of inorganic mercury and plasma thiol status.
    Zalups RK; Lash LH
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):88-97. PubMed ID: 16466761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    Zalups RK; Gelein RM; Cherian MG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1256-66. PubMed ID: 1527728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial protection by chlorpromazine in mercuric chloride-induced acute renal failure in rats.
    Dobyan DC; Bulger RE
    Lab Invest; 1984 May; 50(5):578-86. PubMed ID: 6232424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of exogenous thiols on inorganic mercury-induced injury in renal proximal and distal tubular cells from normal and uninephrectomized rats.
    Lash LH; Putt DA; Zalups RK
    J Pharmacol Exp Ther; 1999 Nov; 291(2):492-502. PubMed ID: 10525063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of inorganic mercury co-administrated with L-cysteine.
    Zalups RK; Barfuss DW
    Toxicology; 1996 May; 109(1):15-29. PubMed ID: 8619249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK
    J Toxicol Environ Health A; 1998 Sep; 55(1):13-29. PubMed ID: 9747601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal accumulation and intrarenal distribution of inorganic mercury in the rabbit: effect of unilateral nephrectomy and dose of mercuric chloride.
    Zalups RK
    J Toxicol Environ Health; 1991 Jun; 33(2):213-28. PubMed ID: 2051495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
    Lash LH; Zalups RK
    J Pharmacol Exp Ther; 1992 May; 261(2):819-29. PubMed ID: 1578387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of inorganic mercury following biliary obstruction and chemically induced glutathione depletion: dispositional changes one hour after the intravenous administration of mercuric chloride.
    Zalups RK; Barfuss DW; Lash LH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):135-44. PubMed ID: 9925797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of renal toxicity in F344 rats gavaged with mercuric chloride for 2 weeks, or 2, 4, 6, 15, and 24 months.
    Dieter MP; Boorman GA; Jameson CW; Eustis SL; Uraih LC
    J Toxicol Environ Health; 1992 Aug; 36(4):319-40. PubMed ID: 1354752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic anion transport and action of gamma-glutamyl transpeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):289-98. PubMed ID: 7785056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
    Zalups RK; Barfuss DW
    Drug Metab Dispos; 1996 Apr; 24(4):480-6. PubMed ID: 8801064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.